3-hydroxy Heptadecanoic Acid
(Synonyms: β-hydroxy Heptadecanoic Acid, 3-hydroxy Heptadecylic Acid, 3-hydroxy Margaric Acid) 目录号 : GC45774A hydroxy fatty acid
Cas No.:40165-89-7
Sample solution is provided at 25 µL, 10mM.
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
3-hydroxy Heptadecanoic acid is a hydroxylated fatty acid. It is a component of LPS in several species of Gram-negative bacteria.1,2 Levels of 3-hydroxy heptadecanoic acid are decreased in the feces of patients with Crohn's disease.
|1. Weintraub, A., Larsson, B.E., and Lindberg, A.A. Chemical and immunochemical analyses of Bacteroides fragilis lipopolysaccharides. Infect. Immun. 49(1), 197-201 (1985).|2. Uhlig, S., Neg•rd, M., Heldal, K.K., et al. Profiling of 3-hydroxy fatty acids as environmental markers of endotoxin using liquid chromatography coupled to tandem mass spectrometry. J. Chromatogr. A 1434, 119-236 (2016).|3. De La Cochetiere, M.F., Rouge, C., Szponar, B., et al. 3-Hydroxy fatty acids in faeces of patients with Crohn's disease or ulcerative colitis as a non-invasive diagnostic approach. Microb. Ecol. Health Dis. 19(1), 1-6 (2007).
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 3.4904 mL | 17.452 mL | 34.904 mL |
5 mM | 0.6981 mL | 3.4904 mL | 6.9808 mL |
10 mM | 0.349 mL | 1.7452 mL | 3.4904 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。